Enfusion, Inc. (ENFN)
Apr 21, 2025 - ENFN was delisted (reason: acquired by CWAN)
10.76
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2025
Enfusion Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 200.21 | 173.29 | 148.69 | 110.38 | 77.99 |
Other Revenue | 1.4 | 1.24 | 1.66 | 1.32 | 1.58 |
| 201.61 | 174.54 | 150.35 | 111.7 | 79.57 | |
Revenue Growth | 15.51% | 16.09% | 34.60% | 40.39% | 34.79% |
Cost of Revenue | 64.87 | 57.64 | 47.1 | 31.85 | 21.36 |
Gross Profit | 136.74 | 116.89 | 103.25 | 79.86 | 58.21 |
Selling, General & Admin | 103.86 | 85.05 | 98.05 | 202.34 | 45.82 |
Research & Development | 26.73 | 19.89 | 17.16 | 153.4 | 6.32 |
Operating Expenses | 130.58 | 104.95 | 115.21 | 355.74 | 52.13 |
Operating Income | 6.16 | 11.95 | -11.96 | -275.88 | 6.07 |
Interest Expense | - | - | - | -4.59 | -1.66 |
Interest & Investment Income | 1.69 | 1.64 | 0.41 | - | - |
Other Non Operating Income (Expenses) | -0.46 | -2.11 | -0.64 | -1.19 | 0.08 |
Pretax Income | 7.39 | 11.48 | -12.19 | -281.66 | 4.49 |
Income Tax Expense | 3.47 | 2.23 | 1.07 | 0.58 | 0.43 |
Earnings From Continuing Operations | 3.92 | 9.25 | -13.26 | -282.24 | 4.06 |
Minority Interest in Earnings | -1.09 | -3.23 | 5.61 | 123.93 | - |
Net Income | 2.82 | 6.03 | -7.65 | -158.32 | 4.06 |
Preferred Dividends & Other Adjustments | - | -0.31 | 0.95 | 29.47 | - |
Net Income to Common | 2.82 | 6.33 | -8.61 | -187.79 | 4.06 |
Net Income Growth | -55.41% | - | - | - | -67.91% |
Shares Outstanding (Basic) | 92 | 88 | 85 | 83 | 0 |
Shares Outstanding (Diluted) | 130 | 129 | 85 | 83 | 0 |
Shares Change | 0.09% | 51.57% | 2.83% | 173025.83% | - |
EPS (Basic) | 0.03 | 0.07 | -0.10 | -2.26 | 84.66 |
EPS (Diluted) | 0.03 | 0.07 | -0.10 | -2.26 | 84.66 |
EPS Growth | -57.73% | - | - | - | - |
Free Cash Flow | 31.05 | 21.18 | 10.17 | -6.41 | -3.4 |
Free Cash Flow Per Share | 0.24 | 0.16 | 0.12 | -0.08 | -70.94 |
Gross Margin | 67.82% | 66.97% | 68.67% | 71.49% | 73.16% |
Operating Margin | 3.05% | 6.85% | -7.96% | -246.99% | 7.63% |
Profit Margin | 1.40% | 3.63% | -5.73% | -168.12% | 5.10% |
Free Cash Flow Margin | 15.40% | 12.14% | 6.77% | -5.74% | -4.28% |
EBITDA | 12.71 | 18.54 | -7.82 | -273.21 | 7.61 |
EBITDA Margin | 6.30% | 10.62% | -5.20% | -244.59% | 9.56% |
D&A For EBITDA | 6.55 | 6.59 | 4.14 | 2.68 | 1.53 |
EBIT | 6.16 | 11.95 | -11.96 | -275.88 | 6.07 |
EBIT Margin | 3.05% | 6.85% | -7.96% | -246.99% | 7.63% |
Effective Tax Rate | 47.02% | 19.43% | - | - | 9.63% |
Revenue as Reported | 201.61 | 174.54 | 150.35 | 111.7 | 79.57 |
Advertising Expenses | 1.8 | 1.5 | 1.5 | 1.2 | 1.3 |